Agenus brain cancer vaccine shows promise in study
(Reuters) - Agenus Inc said more than 90 percent of patients treated with its experimental brain cancer vaccine were alive six months after undergoing...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/jiK4rTjm95I/story01.htm
No comments:
Post a Comment